论文部分内容阅读
笔者自2000年6月起,应用生脉注射液(华西医科大学制药厂提供)合头孢噻肟钠(999南方制药厂提供)治疗肝炎后肝硬化并发自发性细菌性腹膜炎(SBP)患者,取得了较好的疗效,并与单用头孢噻肟钠组进行了随机对照观察。现将结果报告如下。1资料与方法
The author since June 2000, the application of Shengmai injection (Huaxi Medical University Pharmaceutical Factory) and cefotaxime sodium (999 Southern Pharmaceutical Factory) for the treatment of posthepatitic cirrhosis complicated by spontaneous bacterial peritonitis (SBP) patients, obtained A better curative effect, and with a single cefotaxime sodium group were randomized controlled observation. The results reported below. 1 data and methods